Abstract
The incidence of endometrial cancer in the San Francisco area between 1969 and 1979 is compared to trends in estrogen sales and prescriptions. Both estrogen use and endometrial cancer incidence increased steadily until 1975 and then decreased significantly. The data support the previously documented association between endometrial cancer and estrogen use, but suggest that short-term usage may carry only slightly increased risk which can be eliminating entirely upon termination of therapy.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Antunes C. M., Strolley P. D., Rosenshein N. B., Davies J. L., Tonascia J. A., Brown C., Burnett L., Rutledge A., Pokempner M., Garcia R. Endometrial cancer and estrogen use. Report of a large case-control study. N Engl J Med. 1979 Jan 4;300(1):9–13. doi: 10.1056/NEJM197901043000103. [DOI] [PubMed] [Google Scholar]
- Austin D. F., Roe K. M. Increase in cancer of the corpus uteri in the San Francisco-Oakland standard metropolitan statistical area, 1960--75. J Natl Cancer Inst. 1979 Jan;62(1):13–16. [PubMed] [Google Scholar]
- Gray L. A., Sr, Christopherson W. M., Hoover R. N. Estrogens and endometrial carcinoma. Obstet Gynecol. 1977 Apr;49(4):385–389. [PubMed] [Google Scholar]
- Hammond C. B., Jelovsek F. R., Lee K. L., Creasman W. T., Parker R. T. Effects of long-term estrogen replacement therapy. I. Metabolic effects. Am J Obstet Gynecol. 1979 Mar 1;133(5):525–536. doi: 10.1016/0002-9378(79)90288-6. [DOI] [PubMed] [Google Scholar]
- Hulka B. S., Fowler W. C., Jr, Kaufman D. G., Grimson R. C., Greenberg B. G., Hogue C. J., Berger G. S., Pulliam C. C. Estrogen and endometrial cancer: cases and two control groups from North Carolina. Am J Obstet Gynecol. 1980 May 1;137(1):92–101. doi: 10.1016/0002-9378(80)90391-9. [DOI] [PubMed] [Google Scholar]
- Jelovsek F. R., Hammond C. B., Woodard B. H., Draffin R., Lee K. L., Creasman W. T., Parker R. T. Risk of exogenous estrogen therapy and endometrial cancer. Am J Obstet Gynecol. 1980 May 1;137(1):85–91. doi: 10.1016/0002-9378(80)90390-7. [DOI] [PubMed] [Google Scholar]
- Jick H., Watkins R. N., Hunter J. R., Dinan B. J., Madsen S., Rothman K. J., Walker A. M. Replacement estrogens and endometrial cancer. N Engl J Med. 1979 Feb 1;300(5):218–222. doi: 10.1056/NEJM197902013000502. [DOI] [PubMed] [Google Scholar]
- Mack T. M., Pike M. C., Henderson B. E., Pfeffer R. I., Gerkins V. R., Arthur M., Brown S. E. Estrogens and endometrial cancer in a retirement community. N Engl J Med. 1976 Jun 3;294(23):1262–1267. doi: 10.1056/NEJM197606032942304. [DOI] [PubMed] [Google Scholar]
- Smith D. C., Prentice R., Thompson D. J., Herrmann W. L. Association of exogenous estrogen and endometrial carcinoma. N Engl J Med. 1975 Dec 4;293(23):1164–1167. doi: 10.1056/NEJM197512042932302. [DOI] [PubMed] [Google Scholar]
- Walker A. M., Jick H. Declining rates of endometrial cancer. Obstet Gynecol. 1980 Dec;56(6):733–736. [PubMed] [Google Scholar]
- Weiss N. S., Szekely D. R., Austin D. F. Increasing incidence of endometrial cancer in the United States. N Engl J Med. 1976 Jun 3;294(23):1259–1262. doi: 10.1056/NEJM197606032942303. [DOI] [PubMed] [Google Scholar]
- Weiss N. S., Szekely D. R., English D. R., Schweid A. I. Endometrial cancer in relation to patterns of menopausal estrogen use. JAMA. 1979 Jul 20;242(3):261–264. [PubMed] [Google Scholar]
- Ziel H. K., Finkle W. D. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med. 1975 Dec 4;293(23):1167–1170. doi: 10.1056/NEJM197512042932303. [DOI] [PubMed] [Google Scholar]